Tissue graft materials containing biocompatible agent and methods of making and using same

• US 20080063627A1
• Filed: 09/12/2006
• Published: 03/13/2008
• Est. Priority Date: 09/12/2006
• Status: Abandoned Application

• Current Assignee: Surmodics Incorporated
• Original Assignee: Surmodics Incorporated
• Inventors: Heyer, Toni Michelle, Stucke, Sean M.
• Application Number:
  US11/519,647
• Publication Number:
  US 20080063627A1
• Time in Patent Office: Days
• US Class Current: 424/93.7
• CPC Class Codes: A61L 2300/232 Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
• CPC Class Codes: A61L 2300/236 Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
• CPC Class Codes: A61L 2300/254 Enzymes, proenzymes
• CPC Class Codes: A61L 2300/256 Antibodies, e.g. immunoglobulins, vaccines
• CPC Class Codes: A61L 2300/40 characterised by a specific therapeutic activity or mode of action
• CPC Class Codes: A61L 2300/42 Anti-thrombotic agents, anticoagulants, anti-platelet agents
• CPC Class Codes: A61L 2300/432 Inhibitors, antagonists A61L2300/402 - A61L2300/43 take precedence
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3683 subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence

Abstract

The invention provides implantable tissue graft materials composed of a collagenous tissue scaffold and a biocompatible agent bonded to the tissue scaffold via an activated photoreactive group. The invention further provides methods including steps of obtaining a tissue graft material comprising a collagenous tissue scaffold; contacting the collagenous tissue scaffold with a biocompatible agent composition that includes biocompatible agent and one or more photoreactive groups; and treating the collagenous tissue scaffold and biocompatible agent composition to activate the photoreactive groups and bond the biocompatible agent to the tissue scaffold via one or more activated photoreactive groups. Implantable prostheses formed of the tissue graft material are also contemplated.

Claims

1. An implantable tissue graft material comprising a collagenous tissue scaffold and a biocompatible agent bonded to the collagenous tissue scaffold via an activated photoreactive group.

2. The implantable tissue graft material according to claim 1 wherein the collagenous tissue scaffold comprises submucosal tissue.

3. The implantable tissue graft material according to claim 2 wherein the submucosal tissue is isolated from intestinal, alimentary, respiratory, urinary or genital tracts of warm-blooded vertebrates, or connective tissue of warm-blooded vertebrates.

4. The implantable tissue graft material according to claim 1 wherein the biocompatible agent is selected from heparin, heparin derivatives, sodium heparin, low molecular weight heparin, hirudin, polylysine, argatroban, glycoprotein IIb/IIIa platelet membrane receptor antibody, coprotein IIb/IIIa platelet membrane receptor antibody, recombinant hirudin, thrombin inhibitor, chondroitin sulfate, modified dextran, albumin, streptokinase, tissue plasminogen activator, and combinations thereof.

5. The implantable tissue graft material according to claim 1 wherein the biocompatible agent is selected from fibronectin, laminin, collagen, elastin, vitronectin, tenascin, fibrinogen, thrombospondin, osteopontin, von Willibrand Factor, bone sialoprotein, hyaluronic acid, chitosan, methyl cellulose, and combinations thereof.

6. The implantable tissue graft material according to claim 1 wherein the biocompatible agent is a polysaccharide.

7. The implantable tissue graft material according to claim 1 wherein the photoreactive group is pendent from the biocompatible agent.

8. The implantable tissue graft material according to claim 1 wherein the photoreactive group is provided by a photoactivatable crosslinking agent.

9. The implantable tissue graft material according to claim 1 wherein the photoreactive group is selected from acetophenone, benzophenone, anthraquinone, anthrone, anthrone-like heterocycles, and substituted derivatives thereof.

10. The implantable tissue graft material according to claim 1 having biocompatible activity that is increased two-fold or more, relative to an inherent biocompatible activity of the collagenous tissue scaffold.

11. The implantable tissue graft material according to claim 4 wherein the biocompatible agent is heparin, and wherein the tissue scaffold has a heparin activity that is at least 5 mU greater than inherent heparin activity of the tissue scaffold.

12. The implantable tissue graft material according to claim 1 formed into an implantable prosthesis.

13. The implantable prosthesis according to claim 12 wherein the prosthesis is tubular, flat, or of a complex shape.

14. A medical product comprising the tissue graft material according to claim 1 provided within sterile medical packaging.

15. A method comprising steps of:

(a) obtaining a tissue graft material comprising a collagenous tissue scaffold;

(b) contacting the collagenous tissue scaffold with a biocompatible agent composition comprising biocompatible agent and one or more photoreactive groups; and

(c) treating the collagenous tissue scaffold and biocompatible agent composition to activate the photoreactive groups and bond the biocompatible agent to the collagenous tissue scaffold via one or more activated photoreactive groups.

16. The method according to claim 15 wherein the step of obtaining a tissue graft material comprises obtaining a cross-linked collagenous tissue scaffold.

17. The method according to claim 15 wherein the one or more photoreactive groups are pendent from the biocompatible agent.

18. The method according to claim 15 wherein the photoreactive group is selected from acetophenone, benzophenone, anthraquinone, anthrone, anthrone-like heterocycles, and substituted derivatives thereof.

19. The method according to claim 15 wherein the contacting step comprises immersing at least a portion of the collagenous tissue scaffold in the biocompatible agent composition.

20. The method according to claim 15 wherein the treating step comprises irradiating the biocompatible agent composition with light in the ultraviolet or visible regions of the spectrum.

21. The method according to claim 15 further comprising a step (d) forming the tissue graft material containing bonded biocompatible agent into an implantable prosthesis.

22. An implantable prosthesis prepared in accordance with the method of claim 15.

23. A method comprising steps of:

(a) obtaining a tissue graft material comprising a collagenous tissue scaffold;

(b) contacting the collagenous tissue scaffold with a reagent having the formula (X)_m—

Y-Z)_n where X is a photoreactive group, Y is a spacer radical, and Z is a bifunctional aliphatic acid; and

(c) treating the collagenous tissue scaffold and biocompatible agent composition to activate the photoreactive groups and bond the reagent to the collagenous tissue scaffold via one or more activated photoreactive groups.

24. An implantable tissue graft material comprising a collagenous tissue scaffold and a reagent having the formula (X)_m—

Y-Z)_n where X is a photoreactive group, Y is a spacer radical, and Z is a bifunctional aliphatic acid or lysine.

25. A method comprising steps of:

(a) obtaining a tissue graft material comprising a collagenous tissue scaffold;

(b) contacting the collagenous tissue scaffold with a reagent comprising a polymeric backbone bearing one or more pendent photoreactive groups and one or more pendent bioactive groups; and

(c) treating the collagenous tissue scaffold and biocompatible agent composition to activate the photoreactive groups and bond the reagent to the collagenous tissue scaffold via one or more activated photoreactive groups,

wherein the bioactive groups are capable of specific, noncovalent interactions with complementary groups when the collagenous tissue scaffold is implanted in a patient.

26. An implantable tissue graft material comprising a collagenous tissue scaffold and a reagent comprising a polymeric backbone bearing one or more pendent photoreactive groups and one or more pendent bioactive groups, wherein the bioactive groups are capable of specific, noncovalent interactions with complementary groups when the collagenous tissue scaffold is implanted in a patient.